106 related articles for article (PubMed ID: 1151967)
1. Synthesis and pharmacological properties of 4-piperazino-5-methylthiopyrimidines. Selection of new antiemetic agents.
Mattioda G; Obelianne P; Gauthier H; Loiseau G; Millischer R; Donadieu AM; Mestre M
J Med Chem; 1975 Jun; 18(6):553-9. PubMed ID: 1151967
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal prokinetic and antiemetic effects of a new substituted pyrimidinO 6553 (2-methylamino-4-N-methylpiperazino-5-thiomethyl-6-chloropyrimidine hydrochloride).
Loiseau G; Millischer R; Donadieu AM; Marquet JP
Arzneimittelforschung; 1977; 27(3):606-11. PubMed ID: 577427
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationships of 4-amino-5-chloro-N-(1,4-dialkylhexahydro-1,4-diazepin-6-yl)-2-methoxybenzamide derivatives, novel and potent serotonin 5-HT3 and dopamine D2 receptors dual antagonist.
Hirokawa Y; Harada H; Yoshikawa T; Yoshida N; Kato S
Chem Pharm Bull (Tokyo); 2002 Jul; 50(7):941-59. PubMed ID: 12130853
[TBL] [Abstract][Full Text] [Related]
4. Investigations on the synthesis and properties of arylpiperazinylalkyl derivatives of some dihydro- and tetrahydropyrido[2,3-d]pyrimidines.
Sladowska H
Farmaco; 1993 Jan; 48(1):77-84. PubMed ID: 8457279
[TBL] [Abstract][Full Text] [Related]
5. 2-Amino-6-chloro-4-(N-methylpiperazino)pyrimidines, inhibitors of spiroperidol binding.
Guérémy C; Audiau F; Uzan A; Le Fur G; Léger JM; Carpy A
J Med Chem; 1982 Dec; 25(12):1459-65. PubMed ID: 7154006
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity.
Hirokawa Y; Fujiwara I; Suzuki K; Harada H; Yoshikawa T; Yoshida N; Kato S
J Med Chem; 2003 Feb; 46(5):702-15. PubMed ID: 12593651
[TBL] [Abstract][Full Text] [Related]
7. Antivertigo agents. IV. Synthesis and antivertigo activity of 6-[omega-(4-aryl-1-piperazinyl)alkyl]-5,6,7,8-tetrahydro-1,6-naphth yridines.
Shiozawa A; Ichikawa Y; Komuro C; Ishikawa M; Furuta Y; Kurashige S; Miyazaki H; Yamanaka H; Sakamoto T
Chem Pharm Bull (Tokyo); 1984 Oct; 32(10):3981-93. PubMed ID: 6529796
[No Abstract] [Full Text] [Related]
8. 2-[(3-Pyridinylmethyl)thio]pyrimidine derivatives: new bronchosecretolytic agents.
Schickaneder H; Engler H; Szelenyi I
J Med Chem; 1987 Mar; 30(3):547-51. PubMed ID: 3820227
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and some central pharmacological properties of new 5(1H)oxo-2,3-dihydroimidazo[1,2-a]pyrimidine-6-carboxylic esters.
Matosiuk D; Tkaczyński T; Jagiełło-Wójtowicz E; Wielosz M; Szurska G; Chodkowska A; Janusz W; Kleinrok Z
Pol J Pharmacol Pharm; 1992; 44(3):307-18. PubMed ID: 1470568
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and some central pharmacological properties of new derivatives of 2,3-dihydroimidazo[1,2-a]pyrimidine-6-carboxylic acid.
Matosiuk D; Tkaczyński T; Jagiełło-Wójtowicz E; Zebrowska-Lupina I; Czuczwar SJ; Matuszek B; Klenk-Majewska B; Danilczuk Z; Janusz W; Kleinrok Z
Pol J Pharmacol Pharm; 1992; 44(1):67-78. PubMed ID: 1437853
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and pharmacological properties of derivatives of isoxazolo[4,3-d]pyrimidine. III.
Wagner E; Poreba K; Jakowicz I; Balicka D; Rutkowska M; Kedzierska-Goździk L; Szelag A
Farmaco; 1995 Mar; 50(3):183-7. PubMed ID: 7755866
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, chemical and pharmacological properties of some 2,4-dioxo-1,2,3,4,5,6,7,8-octahydropyrimido [4,5-d]pyrimidines.
Sladowska H; Sieklucka-Dziuba M; Rajtar G; Wydro R; Kleinrok Z
Acta Pol Pharm; 1996; 53(1):39-46. PubMed ID: 8960282
[TBL] [Abstract][Full Text] [Related]
13. A new series of 6-chloro-2,3-dihydro-4(1H)-quinazolinone derivatives as antiemetic and gastrointestinal motility enhancing agents.
Baldazzi C; Barbanti M; Basaglia R; Benelli A; Bertolini A; Piani S
Arzneimittelforschung; 1996 Sep; 46(9):911-8. PubMed ID: 8876941
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antibacterial activities of new 1beta-methylcarbapenems having aminopyrimidinylthioether moiety.
Lee KS; Lim JH; Kang YK; Yoo KH; Kim DC; Shin KJ; Kim DJ
Eur J Med Chem; 2006 Nov; 41(11):1347-51. PubMed ID: 16973246
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and pharmacological properties of 2,4-disubstituted 5-amino-6-pyrimidinecarboxylic acid derivatives. Part III.
Jasztold-Howorko R; Machoń Z; Wilimowski M; Wojewódzki W; Barczyńska J; Kedzierska L; Orzechowska-Juzwenko K; Duś E; Dziewiszek W; Rutkowska M
Pol J Pharmacol; 1995; 47(5):435-40. PubMed ID: 8868136
[TBL] [Abstract][Full Text] [Related]
16. BMY-25801, an antiemetic agent free of D2-dopamine receptor antagonist properties.
Gylys JA; Wright RN; Nicolosi WD; Buyniski JP; Crenshaw RR
J Pharmacol Exp Ther; 1988 Mar; 244(3):830-7. PubMed ID: 2978041
[TBL] [Abstract][Full Text] [Related]
17. The antiemetic effects of domperidone, a novel potent gastrokinetic.
Niemegeers CJ; Schellekens KH; Janssen PA
Arch Int Pharmacodyn Ther; 1980 Mar; 244(1):130-40. PubMed ID: 7416883
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598).
Megens AA; Awouters FH; Meert TF; Schellekens KH; Niemegeers CJ; Janssen PA
J Pharmacol Exp Ther; 1992 Jan; 260(1):146-59. PubMed ID: 1370538
[TBL] [Abstract][Full Text] [Related]
19. Development of high-affinity 5-HT3 receptor antagonists. 2. Two novel tricyclic benzamides.
Youssefyeh RD; Campbell HF; Airey JE; Klein S; Schnapper M; Powers M; Woodward R; Rodriguez W; Golec S; Studt W
J Med Chem; 1992 Mar; 35(5):903-11. PubMed ID: 1548679
[TBL] [Abstract][Full Text] [Related]
20. 5-HT3 receptor antagonists. 2. 4-Hydroxy-3-quinolinecarboxylic acid derivatives.
Hayashi H; Miwa Y; Ichikawa S; Yoda N; Miki I; Ishii A; Kono M; Yasuzawa T; Suzuki F
J Med Chem; 1993 Mar; 36(5):617-26. PubMed ID: 8496941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
